Abstract: Exemplary embodiments may include a device with an input power component, a system supply component, an inductive charger component operatively coupled to the input component and the system component, and a direct charger component operatively coupled to the inductive charger and the system component. Exemplary embodiments may further include an input node of the inductive charger component and an input node of the direct charger component operatively coupled to an output node of the input power component at a first device node. Exemplary embodiments may also include a method of receiving an input power signal, obtaining a charging condition, entering a first charging state, in accordance with the obtained charging condition satisfying a first charging condition, and entering a second charging state, in accordance with the obtained charging condition satisfying a second charging condition.

Abstract: The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Abstract: Embodiments of the present systems and methods may provide techniques that may profile and quantify the microbiome and metabolome and identify the novel health, lifestyle, and environmental-related proteins that they affect. Embodiments may provide the capability for the classification of patients or other biological entities into clinical or non-clinical but related groups and labels, based on assessment of their microbiome and metabolome. Embodiments may provide the capability to assess patient health, identify disease risk factors, identify, and rank therapeutic targets, determine the functional contributions of the microbiome to patient health, and even predict outcomes such as disease development and drug response. Other embodiments may provide consumers with lifestyle related information and comparisons with other consumers' data, potentially allowing consumers to tailor lifestyle choices such as nutrition, exercise, and supplementation.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Abstract: The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Abstract: The invention relates to methods and bacterial strains for making terpene and terpenoid products, the bacterial strains having improved carbon pull through the MEP pathway and to a downstream recombinant synthesis pathway.

Abstract: The invention provides methods for making steviol glycosides, including RebM and glycosylation products that are minor products in stevia leaves, and provides enzymes, encoding polynucleotides, and host cells for use in these methods. The invention provides engineered enzymes and engineered host cells for producing steviol glycosylation products, such as RebM, at high purity and/or yield. The invention further provides methods of making products containing steviol glycosides, such as RebM, including food products, beverages, oral care products, sweeteners, and flavoring products.

Abstract: Methods and apparatus adapted for enhancing the throughput of a digital processor (e.g., microprocessor, CISC device, or RISC device) through use of a direct memory access (DMA) mechanism. In one embodiment, the processor comprises a “soft” RISC-based processor core that is both user-extensible and user-configurable. The core comprises a functional process or unit (DMA assist) that is coupled to the processor's extension logic and which facilitates throughput by, among other things, ensuring that the CPU and processor extension logic can operate on data in parallel in an efficient manner. In one variant, a parallel datapath (including a buffer) is used in conjunction with the aforementioned DMA assist so as to permit the processor extension logic to efficiently operate in parallel with the CPU.